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Introduction
Some cases of pneumonia of unknown etiology de-
tected in Wuhan City, Hubei Province of China in the
end of 2019. A total of 44 patients reported with pneu-
monia of unknown cause in January 2020 that have been
reported to World Health Organization (WHO) by the
national authorities in China.1 The consensus statement
then established that the pneumonia of unknown etiolo-
gy is coronavirus disease 2019 (COVID-19).2 As of
March 2020, COVID-19 cases have been found globally
(spread out of China),3 that Centers for Disease Control
and Prevention (CDC) then recognized that the COVID-
19 is person-to-person spread.4,5 In March 11, 2020,
based on the current situation that the COVID-19 have
affected countries outside China tripled and the number
of cases has increased 13-fold outside China, then WHO
identified COVID-19 as pandemic.6
The COVID-19 pandemic has drained a lot of energy,
whether in physical, mental, social and economic terms.7
The calculations have continuously been made to deter-
mine the latest situation of cases that have occurred.
Indeed, it has truly felt that we are living in "one world"
in which no place or country is free from "contamina-
tion" of a problem that has afflicted certain regions.
The Case Fatality Rate (CFR) has especially become
an intriguing subject of discussion for many people.
People cannot avoid of talking the number of death
when they discuss COVID-19. In a way, this moment
has presented a new opportunity for the Indonesian com-
munity to improve their knowledge on mortality meas-
ures. As previously, the CFR was known only to those in
the health sector, but now more people are becoming fa-
miliar with the measure. The CFR is a measure of mor-
tality that is feared by human being for several reasons
such as because death is the ultimate experience that all
human being will surrender. Moreover, death is highly
importance to each person including questions of when
and how death will occur and whether there is any way
to delay it.8-10
On social media, people have been debating the na-
tional CFR and even compared it with CFR of other
countries such as China and Vietnam, which have now
had lower CFR compared to other country. This com-
parison is then followed by comparing the performance
of the Indonesian government in handling pandemics
under the pretext why CFR in Indonesia is higher com-
pared to other countries. Another thing that also hap-
pens is the lots of people displaying CFR numbers in
Indonesia on television or social media which then does
not only make people understand but has the potential
to create excessive fear or anxiety. This is a mistake be-
cause the community is more fixated on its CFR number
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compared to other information behind the CFR.
Therefore, it is very important to provide understanding
to the public or community regarding what is meant by
the CFR and what are its weaknesses.
Method
This is a literature review study. Authors submit that
it needs many considerations to interpret the CFR; and
for that authors present many expert’s views on how the
CFR is calculated and its impact on the community.
Discussion
The Case Fatality Rate (CFR) is a common measure
of the short-term severity of an acute disease; it could be
used to measure any benefit of a new therapy or the ef-
fectiveness of an intervention. The CFR is defined as the
proportion of cases with certain diseases or conditions
that die within a certain time. Generally, the CFR is pre-
sented as a percentage.8-10 It is the proportion of people
with a given disease or condition who die from it in a giv-
en period. In this pandemic context, the CFR is calculat-
ed by dividing the number of COVID-19 patients who
died with the total number of patients with confirmed as
COVID-19 infection. The number of COVID-19 patients
who died is referred to as a numerator while the total
number of COVID-19 infected patients is referred to as
the denominator.8-10 In calculating CFR, it should use
official data that has been confirmed by the party that is-
sued the data. In Indonesia, official data is released by
the Ministry of Health which is published daily both di-
rectly and on the official website.11
To April 27, 2020, the CFR in Indonesia was around
8.4%.11 This figure was relatively high when compared
to other countries such as Singapore, Malaysia or even
China. However, people must be careful in interpreting
and comparing the CFR in Indonesia with other coun-
tries. Let alone with other country, the CFR comparisons
between provinces in Indonesia also vary. This difference
is very reasonable, given the different characteristics of
the regions in Indonesia.12-18
The calculation of CFR is particularly sensitive to the
denominator: the greater the denominator, the smaller
the CFR. The daily CFR figures can change according to
the denominator, which in this case is the number of peo-
ple who have been confirmed as positive COVID-19
based on real-time polymerase chain reaction (PCR)
method. Several factors certainly affect the CFR figures
every day. As we understand, COVID-19 is a new virus
that is still being researched. Much information regarding
the virus is still unknown. The capacity of health services;
the availability of health workers, personal protective
equipment, examination tools for diagnosis; and the
readiness of the central and local governments are several
factors that also affect the CFR.14,15
One of the factors influencing the soaring figures of
the CFR is the limited number of laboratories that can be
used as referral sites for conducting real-time PCR test
all over Indonesia. Initially, Indonesia only used one la -
boratory to conduct the real-time PCR, and this assuredly
yielded a slow diagnosis, which, in effect, generated very
little information (Figure 1). In March 16, 2020, it was
announced that 12 laboratory networks were added, then
other additional 36 laboratories on April 3, and on April
29 it was declared that the total number of laboratories
ready for PCR test was 89. This addition of laboratories,
however, did not necessarily lead to the increase in the
Figure 1. The Trend of Number of Cases Confirmed Along with the Addition of Laboratory in Indonesia
Source: https://covid19.go.id/peta-sebaran
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number of test because Indonesia was constrained by the
limited availability of reagents and experts who were able
to carry out the test.11,19-21
With the addition of laboratories and the difficulties
encountered in the field, and when it compared to the
vastness of Indonesia which consists of 514 districts, the
overall picture, of course, is still unfavourable. Such cir-
cumstances have automatically slowed down the process
of confirmation on people’s status – whether or not they
are infected; so the denominator would be small. In this
case, the CFR tends to be over-estimated. We also under-
stand that there were instances where patients under sur-
veillance died but their results of real-time PCR test were
not yet known. If it was later discovered that the real-
time PCR test results were confirmed to be positive, then
the CFR calculation in the previous time was underesti-
mated because it had not included the numerator.13,15,16
Both of such conditions, underestimation, and over-
estimation of the CFR, have their respective impacts.
Overestimation of the figures may induce fear and panic
while underestimating it may lead to the lack of serious-
ness in the community in preventing and overcoming the
spread of the COVID-19. Thus, in presenting, interpret-
ing and comparing the CFR for the public, caution and
understanding of situations or contexts are indis -
pensable.14
Responding to this situation, we must apply the na-
tional standardization system in the context of laborato-
ries for the equal distribution of the availability and quali -
ty of examinations or diagnoses, so when one day
Indonesian is struck by a similar incident, we would no
longer hear a statement that “the data from Laboratory A
is unreliable” or “unconfirmed”. The minimum standard
must be prepared for each province, and if possible, be
extended to the district or city level.7,11
Another thing of concern is the effort for modelling
the COVID-19 incident, which has been confusing to the
public. Every academic and research institution has con-
ducted modelling and each modelling has been developed
with an assumption. Different models were from differ-
ent assumptions, and this is not even easily understood
by many people. Determining when transmission occurs
also need to be assumed if the model is to be calculated
properly. The determination of the initial transmission
can be traced back from the first positive cases reported,
where these cases are continuously traced until it be-
comes possible to seize cases that have not been previ-
ously diagnosed – but because of a proper symptom
recording – could show symptoms identical to the initial-
ly diagnosed cases. Hence, we would be able to establish
a diagnosis by running this method properly until the first
transmission is assuredly discovered. Another option is
to simply stop at the first confirmed case and pay atten-
tion to the average transmission, hence an initial case can
be determined and a model with various assumptions be
built. The ability to trace back, known as disease epi-
demiological research, is also important to be carried out
by the health department in each district or city to assist
in the discovery of new cases as well as to detect the
source of morbidity, which can help in handling a case of
illness.22-25
Conclusion
Finally, this pandemic has inevitably demanded peo-
ple to understand the measures used in public health
problems. However, displaying the size of public health
problems without further explanation may cause infor-
mation bias in the community, which can potentially cre-
ate adverse interpretations and conclusions. Therefore,
health information, especially about the size of public
health problems, need to be displayed with explanations
of strengths and weaknesses. This is an opportunity to
provide more education to the public considering that
50% of Indonesia's population has been connected to
the internet and almost all Indonesians can access televi-
sion. Thus, this difficult pandemic would not just pass by
but also provide a learning effect for all Indonesians.
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